Abstract:Vincristine, a chemotherapeutic microtubule formation inhibitor, is used to treat all stages of prostate cancer. To enhance drug delivery at the specific site and increase the efficiency of sustained therapy, a targeted nanoformulation (NF) polymeric-based drug delivery approach with ligand surface modification was designed. The NF of thiolated chitosan (TC) coated with hyaluronic acid (HA) and loaded with vincristine (VC) by an ionic gelation process was synthesized and characterized. Insilico studies confirmed the attachment of HA with the CD44 receptor at binding sites A & B in prostate cancer cells. The zeta analysis showed an average particle size of 267.9 nm, PDI 0.210, and +15.1 zeta potential while FTIR confirmed the thiolated group in NF and Raman analysis confirmed the presence of hydrophilic groups, porous surface, and agglomeration features upon drug-polymer interaction. SEM and TEM showed spherical-shaped nanoparticles with smooth surfaces, whereas XRD confirmed the crystalline nature which makes NF very useful in targeted drug delivery systems. DSC confirmed the stability of NF at a high temperature greater than 100 °C. The drug loading and encapsulation efficiencies of the NF were 41.4 and 87% respectively, while the kinetics study of drug release showed that the NF followed the simple diffusion by the Higuchi square root of time equation in an acidic medium. The in vitro study showed sustained steady release at pH 7.4 and 6.8 up to 72 h As compared to short-term fast release in almost 12 h of conventional VC. The in vitro anticancer activity of the TCs-HA loaded with vincristine was checked by an MTT assay on normal prostate epithelial cells (HPrEC with IC50 of 16.2 μg/ml) and cancerous prostate cells (PC3 with IC50 of 32 μg/ml) at doses of 10–90 μg/ml in comparison to raw vincristine, which confirmed the strong cytotoxic potential of the prepared NF at lower doses and safety for normal prostate cells. All these properties enhance the sustainability, efficacy, and active targeting of NFs as a potent targeted therapeutic moiety in cancer treatment.

Hyaluronic Acid-Coated Cationic Nanostructured Lipid Carriers for Oral Vincristine Sulfate Delivery

Development of lipid nanoparticles for a histone deacetylases inhibitor as a promising anticancer therapeutic

Hyaluronic acid and cholecalciferol conjugate based nanomicelles: Synthesis, characterization, and cytotoxicity against MCF-7 breast cancer cells

Nonspecifically Enhanced Therapeutic Effects of Vincristine on Multidrug-Resistant Cancers when Coencapsulated with Quinine in Liposomes

Preparation and Characterization of Vinpocetine Loaded Nanostructured Lipid Carriers (NLC) for Improved Oral Bioavailability

Preparation of Hyaluronic Acid-Coated Resveratrol Nanomicelles and Its In Vitro Evaluation

Folic acid and cell-penetrating peptide conjugated PLGA-PEG bifunctional nanoparticles for vincristine sulfate delivery.

Biodegradable Self-Assembled Micelles Based on MPEG-PTMC Copolymers: An Ideal Drug Delivery System for Vincristine

Formulation of surface-functionalized hyaluronic acid-coated thiolated chitosan nano-formulation for the delivery of vincristine in prostate cancer: A multifunctional targeted drug delivery approach

Enhanced Cellular Uptake of Folic Acid–conjugated PLGA–PEG Nanoparticles Loaded with Vincristine Sulfate in Human Breast Cancer

Development of a stable single-vial liposomal formulation for vincristine

Formulation and Characterization of Spray-Dried Powders Containing Vincristine-Liposomes for Pulmonary Delivery and Its Pharmacokinetic Evaluation From In Vitro and In Vivo

Research on the loading and release kinetics of the vincristine sulfate liposomes and its anti-breast cancer activity

Vincristine-doxorubicin co-loaded artificial low-density lipoproteins towards solid tumours

Preparation and quality evaluation of vincristine sulfate-loaded PEG-PLGA nanoparticles

Multifunctional nanoparticles as nanocarrier for vincristine sulfate delivery to overcome tumor multidrug resistance.

Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide

Delivery of vincristine sulfate-conjugated gold nanoparticles using liposomes: a light-responsive nanocarrier with enhanced antitumor efficiency

Advances in the study of vincristine: an anticancer ingredient from Catharanthus roseus]

Selection of transdermal drug delivery system for vincristrine and research on the transdermal mechanism

Preparation and in vitro evaluation of vincristine-loaded superparamagnetic iron oxide nanoparticles